{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T05:18:51Z","timestamp":1648617531335},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.leukres.2010.01.028","type":"journal-article","created":{"date-parts":[[2010,2,19]],"date-time":"2010-02-19T09:17:55Z","timestamp":1266571075000},"page":"1390-1394","source":"Crossref","is-referenced-by-count":2,"title":["Differential NOD\/SCID mouse engraftment of peripheral blood CD34+ cells and JAK2V617F clones from patients with myeloproliferative neoplasms"],"prefix":"10.1016","volume":"34","author":[{"given":"Tsz-Kan","family":"Fung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice M.S.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yok-Lam","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anskar Y.H.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.leukres.2010.01.028_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.beha.2006.11.005","article-title":"The chronic myeloproliferative disorders and mutation of JAK2: Dameshek's 54 year old speculation comes of age","volume":"20","author":"Kaushansky","year":"2007","journal-title":"Best Pract Res Clin Haematol"},{"issue":"7037","key":"10.1016\/j.leukres.2010.01.028_bib2","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.leukres.2010.01.028_bib3","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"issue":"9464","key":"10.1016\/j.leukres.2010.01.028_bib4","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.leukres.2010.01.028_bib5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.leu.2405043","article-title":"Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F","volume":"22","author":"Shide","year":"2008","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.leukres.2010.01.028_bib6","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1182\/blood-2007-05-091579","article-title":"Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice","volume":"111","author":"Xing","year":"2008","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.leukres.2010.01.028_bib7","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1182\/blood-2005-12-4824","article-title":"Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model","volume":"107","author":"Wernig","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2010.01.028_bib8","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood-2006-02-002030","article-title":"JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis","volume":"108","author":"Lacout","year":"2006","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.leukres.2010.01.028_bib9","doi-asserted-by":"crossref","first-page":"11156","DOI":"10.1158\/0008-5472.CAN-06-2210","article-title":"Characterization of murine JAK2V617F-positive myeloproliferative disease","volume":"66","author":"Bumm","year":"2006","journal-title":"Cancer Res"},{"issue":"16","key":"10.1016\/j.leukres.2010.01.028_bib10","doi-asserted-by":"crossref","first-page":"6224","DOI":"10.1073\/pnas.0601462103","article-title":"The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation","volume":"103","author":"Jamieson","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.leukres.2010.01.028_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood-2006-03-007146","article-title":"Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis","volume":"190","author":"Delhommeau","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.01.028_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1349.001","article-title":"Acute myeloid leukemia stem cells","volume":"1044","author":"Dick","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"10.1016\/j.leukres.2010.01.028_bib13","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.exphem.2007.07.005","article-title":"Behavior of CD34+ cells isolated from patients with polycythemia vera in NOD\/SCID mice","volume":"35","author":"Ishii","year":"2007","journal-title":"Exp Hematol"},{"issue":"6","key":"10.1016\/j.leukres.2010.01.028_bib14","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1182\/blood-2008-02-137877","article-title":"The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity","volume":"112","author":"James","year":"2008","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.leukres.2010.01.028_bib15","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.leu.2404721","article-title":"Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD\/SCID engrafting potential","volume":"21","author":"Cheung","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2010.01.028_bib16","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1182\/blood-2005-12-013748","article-title":"Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations and role in leukemic transformation","volume":"108","author":"Campbell","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2010.01.028_bib17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood-2006-12-062125","article-title":"Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation","volume":"110","author":"Theocharides","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2010.01.028_bib18","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1182\/blood-2004-06-2485","article-title":"The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis","volume":"105","author":"Xu","year":"2005","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.leukres.2010.01.028_bib19","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1182\/blood.V92.7.2556","article-title":"Nonobese diabetic\/severe combined immunodeficiency (NOD\/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells","volume":"92","author":"van der Loo","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.01.028_bib20","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1196\/annals.1349.013","article-title":"Distinct gene expression pattern of malignant hematopoietic stem and progenitor cells in polycythemia vera","volume":"1044","author":"Steidl","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"10.1016\/j.leukres.2010.01.028_bib21","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood-2005-05-1800","article-title":"JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia","volume":"106","author":"Jelinek","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2010.01.028_bib22","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1182\/blood-2005-11-009605","article-title":"Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders","volume":"108","author":"Kralovics","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2010.01.028_bib23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.exphem.2006.11.012","article-title":"Polycythemia vera is not initiated by JAK2V617F mutation","volume":"35","author":"Nussenzveig","year":"2007","journal-title":"Exp Hematol"},{"issue":"22","key":"10.1016\/j.leukres.2010.01.028_bib24","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","article-title":"Mutation in TET2 in myeloid cancers","volume":"360","author":"Delhommeau","year":"2009","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.leukres.2010.01.028_bib25","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1038\/leu.2009.141","article-title":"Mutations of ASXL1 gene in myeloproliferative neoplasms","volume":"23","author":"Carbuccia","year":"2009","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.leukres.2010.01.028_bib26","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.exphem.2009.07.003","article-title":"Clonal analyses define the relationships between chromosomal abnormalities and JAK2V617F in patients with Ph-negative myeloproliferative neoplasms","volume":"37","author":"Wang","year":"2009","journal-title":"Exp Hematol"},{"issue":"4","key":"10.1016\/j.leukres.2010.01.028_bib27","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/ng.341","article-title":"A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms","volume":"41","author":"Olcaydu","year":"2009","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.leukres.2010.01.028_bib28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/ng.334","article-title":"JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms","volume":"41","author":"Jones","year":"2009","journal-title":"Nat Genet"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610000597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610000597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T02:48:53Z","timestamp":1590634133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212610000597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0145212610000597"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2010.01.028","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}